Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
that Peter Hewett will be retiring from the Company’s Board of Directors
and will not seek reelection at the upcoming Annual General Meeting. Mr.
Hewett has been a Director of Orthofix since March of 1992. He was the
Deputy Group Chairman between March 1998 and December 2000, and has
served as the Deputy Chairman of the Board beginning in 2005.
“Peter has been a key member of Orthofix’s Board of Directors for 17
years. His broad international business background brought immeasurable
operating knowledge to Orthofix that aided in the Company’s consistent
organic and inorganic growth over a number of years. Peter’s human
resource skills have also served the Company well as he has been a
mentor and advisor for many members of the Board and the senior
management team. I personally have enjoyed my long interaction with
Peter and have gained a lot from his wisdom and his counsel,” said James
F. Gero, Chairman of the Board of Orthofix International.
Mr. Hewett stated, “My time on the Board, which has been a period of
rapid growth and development for Orthofix, has been deeply fulfilling.
Orthofix has always been able to attract talented Board members and it
has been a privilege to serve with them all. I believe that the current
Board, our senior management and our employees are as strong and capable
as at any time in the company’s history, and that the coming years are
full of promise. The future of Orthofix is in excellent hands.”
About Orthofix
Orthofix International, N.V., a global medical device company, offers a
broad line of minimally invasive surgical, and non-surgical, products
for the spine, orthopedic, and sports medicine market sectors that
address the lifelong bone-and-joint health needs of patients of all
ages–helping them achieve a more active and mobile lifestyle. Orthofix’s
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix’s sales representatives and its subsidiaries,
including BREG, Inc. and Blackstone Medical, Inc., and via partnerships
with other leading orthopedic product companies. In addition, Orthofix
is collaborating in R&D partnerships with leading medical institutions
such as the Musculoskeletal Transplant Foundation, the Orthopedic
Research and Education Foundation, Rutgers University, Texas Scottish
Rite Hospital for Children and National Osteoporosis Institute.
